{"id":408384,"date":"2021-01-05T08:03:32","date_gmt":"2021-01-05T13:03:32","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=408384"},"modified":"2021-01-05T08:03:32","modified_gmt":"2021-01-05T13:03:32","slug":"enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\/","title":{"rendered":"ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS  10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, NY, Jan.  05, 2021  (GLOBE NEWSWIRE) &#8212; Enzo Biochem, Inc. (NYSE:ENZ) (\u201cEnzo\u201d or \u201cThe Company\u201d), a leading biosciences and diagnostics company, today announced that it will participate in the 10<sup>th<\/sup>\u00a0Annual LifeSci Partners Corporate Access Event,\u00a0January 6-8\u00a0and 11-14, 2021 in concurrence with J.P. Morgan\u2019s 39<sup>th<\/sup> Annual Healthcare Conference.<\/p>\n<p align=\"justify\">Barry Weiner, President, and David Bench, Chief Financial Officer, will host virtual 1&#215;1 meetings during both sessions of the event as well as present a corporate update on Wednesday, January 6<sup>th<\/sup> at 1pm EST. \u00a0<\/p>\n<p align=\"justify\">To register or to listen to the presentation as well as to request a meeting, please visit the following registration link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ddbo1MVGTXez_vS5Dz0hz4BV_AAL3vIch_MgiuiXtLCPL7oMiNocZjn8iYkoNO7inf4aV63d3PSak7akDlkZArMvZG_wyVaLoCR1Ijlc1h2HNqGQUMVgTz23LZIXQ-1q\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>http:\/\/lifesci.events\/LifeSci2021<\/u><\/a><\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=p3odJmZd8AenxDeAu2KyU5ATeI7oHGcJVLrb8Timxu4hWJDLfKG33BjWuaOGCLpqcOqTs67Lop2yNad2DrGXVA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n          <b><br \/>\n            <u>About Enzo Biochem<\/u><br \/>\n          <\/b><br \/>\n        <\/a><br \/>\n        <b><br \/>\n          <br \/>\n        <\/b><br \/>\n        <b>\u00a0<br \/><\/b>Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform technologies that provide numerous advantages over previous standards. A global company, Enzo Biochem utilizes cross-functional teams to develop and deploy products, systems and services that meet the ever-changing and rapidly growing needs of health care today and into the future. Underpinning Enzo Biochem\u2019s products and technologies is a broad and deep intellectual property portfolio, with patent coverage across a number of key enabling technologies.<\/p>\n<p align=\"justify\">\n        <b><br \/>\n          <u>Forward-Looking Statements<\/u><br \/>\n        <\/b>\n      <\/p>\n<p align=\"justify\">Except for historical information, the matters discussed in this release may be considered &#8220;forward-looking&#8221; statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including those related to cash flow, gross margins, revenues, and expenses which are dependent on a number of factors outside of the control of the Company including, inter alia, the markets for the Company\u2019s products and services, costs of goods and services, other expenses, government regulations, litigation, and general business conditions. See Risk Factors in the Company\u2019s Form 10-K for the fiscal year ended July 31, 2020. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties that could materially affect actual results. The Company disclaims any obligations to update any forward-looking statement as a result of developments occurring after the date of this release.<\/p>\n<p align=\"center\">###<\/p>\n<p align=\"left\">\n        <br \/>Contact:<\/p>\n<p>For Enzo Biochem, Inc.<\/p>\n<p>David Bench, CFO<br \/> 212-583-0100<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JReVVA7k5GGbUdWx6YFNA8gyppPvt4dBP446ioUHqEZOyD3Aa7UlJmzqsPvHT4RtKT92X2s51JWRHP0SJKIQqA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>dbench@enzo.com<\/u><\/a><\/p>\n<p>Media: <\/p>\n<p>Marisa Monte\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <br \/>Berry &amp; Company Public Relations<br \/>212-253-8881<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EC7dCns4Tg088yIs42iy5SqPaNsVlKm8NO9EFxKGSg1qiKWkyBDuEEt-cGYGXOrBrhZixoaczQavGG_4UjmwYTyhJykjALeRJfbnQlglF_8=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>mmonte@berrypr.com<\/u><\/a><\/p>\n<p>Investors:<\/p>\n<p>Jeremy Feffer<br \/>LifeSci Advisors, LLC<br \/>212-915-2568<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RefQX2J1IKbARzJ6ywCVEKK-r5ylBlewbaw-UTJlIhZDme33143-8Tz42zQ6Dkz7en_Rl0-xI6SQ0UdFDzfe7fPLYxNwPHT4PdiLjeBw-Ka1eP0DewbmgYR5cZ9i5phM\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>jeremy@lifesciadvisors.com<\/u><\/a><\/p>\n<p>Steve Anreder<br \/>Anreder &amp; Company<br \/>212-532-3232<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8KvOnxi5u0gHA9ozehDXFi4xYVbtevmdSG5GhQKMQ1fP-9EyIubZXowMbr2x_Z8_Up4fkPX0QLiJ6YYym5XSFAGc8IjKf5Wkp8ZcCi_CUaikb-NH4CXae71eegrz9OPI\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Steven.anreder@anreder.co<\/u><u>m<\/u><\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDM4NiMzOTA0MTA3IzUwMDA3MTYzNQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/c055c75e-e0cd-4456-b1b9-29f2b05eb822\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) &#8212; Enzo Biochem, Inc. (NYSE:ENZ) (\u201cEnzo\u201d or \u201cThe Company\u201d), a leading biosciences and diagnostics company, today announced that it will participate in the 10th\u00a0Annual LifeSci Partners Corporate Access Event,\u00a0January 6-8\u00a0and 11-14, 2021 in concurrence with J.P. Morgan\u2019s 39th Annual Healthcare Conference. Barry Weiner, President, and David Bench, Chief Financial Officer, will host virtual 1&#215;1 meetings during both sessions of the event as well as present a corporate update on Wednesday, January 6th at 1pm EST. \u00a0 To register or to listen to the presentation as well as to request a meeting, please visit the following registration link: http:\/\/lifesci.events\/LifeSci2021 About Enzo Biochem \u00a0Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS  10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-408384","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) &#8212; Enzo Biochem, Inc. (NYSE:ENZ) (\u201cEnzo\u201d or \u201cThe Company\u201d), a leading biosciences and diagnostics company, today announced that it will participate in the 10th\u00a0Annual LifeSci Partners Corporate Access Event,\u00a0January 6-8\u00a0and 11-14, 2021 in concurrence with J.P. Morgan\u2019s 39th Annual Healthcare Conference. Barry Weiner, President, and David Bench, Chief Financial Officer, will host virtual 1&#215;1 meetings during both sessions of the event as well as present a corporate update on Wednesday, January 6th at 1pm EST. \u00a0 To register or to listen to the presentation as well as to request a meeting, please visit the following registration link: http:\/\/lifesci.events\/LifeSci2021 About Enzo Biochem \u00a0Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence &hellip; Continue reading &quot;ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-05T13:03:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDM4NiMzOTA0MTA3IzUwMDA3MTYzNQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT\",\"datePublished\":\"2021-01-05T13:03:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\\\/\"},\"wordCount\":441,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDM4NiMzOTA0MTA3IzUwMDA3MTYzNQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\\\/\",\"name\":\"ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDM4NiMzOTA0MTA3IzUwMDA3MTYzNQ==\",\"datePublished\":\"2021-01-05T13:03:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDM4NiMzOTA0MTA3IzUwMDA3MTYzNQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDM4NiMzOTA0MTA3IzUwMDA3MTYzNQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\/","og_locale":"en_US","og_type":"article","og_title":"ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT - Market Newsdesk","og_description":"NEW YORK, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) &#8212; Enzo Biochem, Inc. (NYSE:ENZ) (\u201cEnzo\u201d or \u201cThe Company\u201d), a leading biosciences and diagnostics company, today announced that it will participate in the 10th\u00a0Annual LifeSci Partners Corporate Access Event,\u00a0January 6-8\u00a0and 11-14, 2021 in concurrence with J.P. Morgan\u2019s 39th Annual Healthcare Conference. Barry Weiner, President, and David Bench, Chief Financial Officer, will host virtual 1&#215;1 meetings during both sessions of the event as well as present a corporate update on Wednesday, January 6th at 1pm EST. \u00a0 To register or to listen to the presentation as well as to request a meeting, please visit the following registration link: http:\/\/lifesci.events\/LifeSci2021 About Enzo Biochem \u00a0Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence &hellip; Continue reading \"ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-05T13:03:32+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDM4NiMzOTA0MTA3IzUwMDA3MTYzNQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT","datePublished":"2021-01-05T13:03:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\/"},"wordCount":441,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDM4NiMzOTA0MTA3IzUwMDA3MTYzNQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\/","name":"ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDM4NiMzOTA0MTA3IzUwMDA3MTYzNQ==","datePublished":"2021-01-05T13:03:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDM4NiMzOTA0MTA3IzUwMDA3MTYzNQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDM4NiMzOTA0MTA3IzUwMDA3MTYzNQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408384","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=408384"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408384\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=408384"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=408384"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=408384"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}